| 今开：0.0 | 昨收：0.556 |
| 最高：0.0 | 最低：0.0 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.8442791E7 |
$中大制药(CNAT)$ 8-K Current report, items 2.01, 3.03, 5.01, 5.02, 5.03, and 9.01 Accession Number: 0001193125-20-152366 Act: 34 Size: 422 KB 网页链接
$中大制药(CNAT)$ 内部交易: 2020-05-22,Director,Mento Steven J ,期权,65000普通股, $0.00
$中大制药(CNAT)$ 内部交易: 2020-05-22,EVP, R&D and CSO,Spada Alfred P. ,期权,31343普通股, $0.00
$中大制药(CNAT)$ 内部交易: 2020-05-22,EVP, COO & CFO,Marshall Keith W ,期权,38500普通股, $0.00
$中大制药(CNAT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-014288 Size: 9 KB 网页链接
$中大制药(CNAT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-014290 Size: 10 KB 网页链接
$中大制药(CNAT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-014293 Size: 9 KB 网页链接
$中大制药(CNAT)$ 8-K Current report, item 5.07 Accession Number: 0001193125-20-148679 Act: 34 Size: 31 KB 网页链接
$中大制药(CNAT)$ 425 Prospectuses and communications, business combinations Accession Number: 0001193125-20-145029 Act: 34 Size: 25 KB 网页链接
$中大制药(CNAT)$ 425 Prospectuses and communications, business combinations Accession Number: 0001193125-20-142782 Act: 34 Size: 37 KB 网页链接